Try our Advanced Search for more refined results

Expert Analysis

How FDA's Adverse Event Reporting System Impacts Drug Cos.

Law360, New York (August 8, 2013, 1:15 PM EDT) -- For those companies that missed it, the 2007 Food and Drug Administration Amendments Act (FDAAA) requires that the U.S. Food and Drug Administration publish quarterly reports that list "potential signals of serious risks/new safety information" of FDA approved medications. Although the FDA's processes and procedures for evaluating risks sufficient enough to warrant publication in these reports are unclear, drug companies with FDA-approved drugs on the market should know about these requirements....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!